Danaher Co. (NYSE:DHR) had its price target lowered by RBC Capital from $93.00 to $87.00 in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has a sector perform rating on the stock.

Danaher (NYSE:DHR) traded down 0.80% on Wednesday, reaching $85.96. The company’s stock had a trading volume of 2,729,532 shares. The company has a market capitalization of $59.04 billion and a price-to-earnings ratio of 18.13. The firm’s 50 day moving average price is $89.53 and its 200-day moving average price is $90.26. Danaher has a 1-year low of $81.25 and a 1-year high of $97.62.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 26th. The company reported $1.27 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.27. During the same period last year, the firm earned $1.04 earnings per share. The firm had revenue of $5.88 billion for the quarter, compared to the consensus estimate of $6.03 billion. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. Equities analysts forecast that Danaher will post $4.86 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Monday, December 21st were paid a dividend of $0.135 per share. The ex-dividend date of this dividend was Thursday, December 17th. This represents a $0.54 annualized dividend and a yield of 0.63%. This is an increase from Danaher’s previous quarterly dividend of $0.03.

A number of other equities research analysts have also weighed in on the company. BTIG Research reaffirmed a buy rating and set a $105.00 target price on shares of Danaher in a research report on Wednesday, January 27th. Deutsche Bank decreased their target price on Danaher from $88.00 to $83.00 in a research report on Thursday, January 21st. Citigroup Inc. began coverage on Danaher in a research report on Thursday, January 21st. They set a neutral rating and a $95.00 target price for the company. Barclays lifted their target price on Danaher from $97.00 to $99.00 and gave the company an overweight rating in a research report on Tuesday, January 19th. Finally, Credit Suisse lifted their price target on Danaher from $90.00 to $97.00 and gave the company a neutral rating in a report on Monday, December 14th. Eight investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $96.35.

In other news, EVP James A. Lico sold 55,840 shares of the business’s stock in a transaction dated Tuesday, November 24th. The stock was sold at an average price of $96.40, for a total value of $5,382,976.00. Following the completion of the transaction, the executive vice president now owns 135,405 shares of the company’s stock, valued at approximately $13,053,042. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 25,300 shares of the business’s stock in a transaction dated Wednesday, January 27th. The shares were sold at an average price of $83.98, for a total value of $2,124,694.00. Following the completion of the transaction, the chief executive officer now directly owns 115,823 shares of the company’s stock, valued at approximately $9,726,815.54. The disclosure for this sale can be found here.

Several institutional investors recently modified their holdings of the stock. Beacon Capital Management bought a new position in shares of Danaher during the fourth quarter valued at about $0. River & Mercantile Asset Management acquired a new position in Danaher during the fourth quarter worth $106,000. Leith Wheeler Investment Counsel acquired a new position in Danaher during the fourth quarter worth $201,000. Beacon Financial Group acquired a new position in Danaher during the fourth quarter worth $248,000. Finally, Ballentine Partners LLC boosted its position in Danaher by 4.1% in the fourth quarter. Ballentine Partners LLC now owns 2,777 shares of the company’s stock worth $258,000 after buying an additional 109 shares during the last quarter.

Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

12 Month Chart for NYSE:DHR

Receive News & Ratings for Danaher Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Co. and related companies with MarketBeat.com's FREE daily email newsletter.